CORCORAN GAVIN (EVP of R&D) received a stock award from SIO GENE THERAPIES INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/15/2020ACC: 0001209191-20-036804
Officer· EVP of R&D
Since Jul 2018
-6.21K
Net shares
Net seller
$21.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
16K acquired · 22.21K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+16K
Price / share
—
Trade value
—
% of position
New position
6/12/2020
0.00→16K
Common Shares
Direct
Shares
−6.21K
Price / share
$3.46
Trade value
$21.49K
% of position
38.8%
6/12/2020
16K→9.79K
Total
Net shares
+9.79K
Net value
-$21.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/12/2020 | A · Award | +16K | — | — | New position | 0.00 | 16K |
| Common Shares Direct | 6/12/2020 | F · Tax Withholding | −6.21K | $3.46 | $21.49K | 38.8% | 16K | 9.79K |
| Total | +9.79K | -$21.49K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Shares
16K shares
Shares
−16K
Strike price
Held after
16K
Exercisable
—
6/12/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares16K shares | 6/12/2020 | D · Disposition | −16K | — | 16K |